ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements with these filters
Ajanta Pharma Ltd reported net profit of ₹274 Cr (+17.6% YoY) for Q3 FY26.
Ajanta Pharma's promoters have submitted a declaration under SEBI Takeover Regulations for the financial year ended March 31, 2026. The filing confirms that no new direct or indirect encumbrances were made on promoter shares during the year, other than those already disclosed.
Ajanta Pharma Limited promoter Aayush Agrawal, trustee of Aayush Agrawal Trust, has created a pledge on 3,85,000 equity shares (0.31% of share capital) on March 30, 2026. This action was taken to increase an existing loan facility. Investors should monitor promoter pledge levels as they indicate financial leverage.